Physostigmine Salicylate (Cardinal Health)
Welcome to the PulseAid listing for the Physostigmine Salicylate drug offered from Cardinal Health. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Cardinal Health |
NON-PROPRIETARY NAME: | Physostigmine Salicylate |
SUBSTANCE NAME: | PHYSOSTIGMINE SALICYLATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
START MARKETING DATE: | 2010-08-10 |
END MARKETING DATE: | 2018-11-30 |
Physostigmine Salicylate HUMAN PRESCRIPTION DRUG Details:
Item Description | Physostigmine Salicylate from Cardinal Health |
LABELER NAME: | Cardinal Health |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1(mg/mL) |
START MARKETING DATE: | 2010-08-10 |
END MARKETING DATE: | 2018-11-30 |
PRODUCT ID: | 55154-1281_1a3e5d1d-4fd4-461c-93c7-9c51d1da96fc |
PRODUCT NDC: | 55154-1281 |
APPLICATION NUMBER: | |
Other PHYSOSTIGMINE SALICYLATE Pharmaceutical Manufacturers / Labelers: